E. Ohman J:Or Asset Management Ab Abiomed Inc Transaction History

E. Ohman J:Or Asset Management Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 05, 2024	SELL	$0.0 - $381.3 $0 - $762,600	-2,000 Closed	0 $0
Q3 2022 Apr 05, 2024	SELL	$242.49 - $301.46 $121,245 - $150,730	-500 Reduced 20.0%	2,000 $491 Million
Q4 2021 Apr 05, 2024	BUY	$300.63 - $371.35 $751,575 - $928,375	2,500 New	2,500 $898 Million
Q4 2019 Apr 05, 2024	SELL	$159.31 - $223.54 $753,058 - $1.06 Million	-4,727 Closed	0 $0
Q3 2019 Apr 05, 2024	BUY	$175.89 - $279.23 $211,067 - $335,076	1,200 Added 34.02%	4,727 $841 Million

Q2 2019 Apr 05, 2024	BUY	$250.96 - $284.94 $583,983 - $663,055	2,327 Added 193.92%	3,527 $919 Million
Q1 2019 Apr 05, 2024	BUY	$276.39 - $362.25 $331,668 - $434,700	1,200 New	1,200 $343 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.